| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |